• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Depression, anxiety prevalent among adults with lymphoma, multiple myeloma

by | Apr 1, 2025 | Uncategorized

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or depression, according to study results.Those symptoms correlated with reduced quality of life.Oreofe O. Odejide, MD, MPH, associate professor of...

Quadruplet Regimen Preferable to Triplets in Multiple Myeloma

by | Mar 27, 2025 | Uncategorized

Source: CureToday articles Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit. Read More

Daratumumab regimen improves survival in transplant-ineligible multiple myeloma

by | Mar 27, 2025 | Uncategorized

The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed multiple myeloma, study results showed.The findings, published in Nature Medicine, support quadruplet therapy with subcutaneous daratumumab...

Communication is Key When Transitioning Multiple Myeloma Care

by | Mar 26, 2025 | Uncategorized

Source: CureToday articles A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit. Read More

Darzalex Plus Revlimid Improves Outcomes in Newly Diagnosed Myeloma

by | Mar 18, 2025 | Uncategorized

Source: CureToday articles Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell transplantation in multiple myeloma. Read More

First relapse in multiple myeloma: the patient perspective

by | Mar 18, 2025 | Uncategorized

Source: CureToday articles Post Content Read More
« Older Entries
Next Entries »

Recent Content

  • Molecular profiling and risk stratification in solitary bone plasmacytoma
  • Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials
  • Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT